Search results
Results from the WOW.Com Content Network
As of 2018, J&J committed to working with the Indian government to support all Indian ASR patients. In late 2018, an Indian government report, the accuracy of which has been disputed by J&J, proposed that each patient who had a faulty implant should receive a lump sum payment of ₹2 million ( US$27,812 ).
Beyond that, the company reported that “multiple products of Johnson & Johnson subsidiaries are subject to numerous product liability claims and lawsuits.” Two other allegedly faulty J&J products targeted by the plaintiffs lawyers were a device called a transvaginal mesh patch and an artificial hip implant.
Between its massive over-the-counter children's medicines recall back in 2010 to its recent headache-inducing hip implant recalls, J&J Johnson & Johnson's OneTouch Proves Not All Recalls Are Alike ...
At 120,000 square feet (11,000 m 2), this facility occupies a fraction of the J&J campus, which encompasses 69 acres (280,000 m 2) in total. Manufacturing at JJM began in February 2008. On August 24, 2010, DePuy recalled [4] all ASR hip implant systems sold since 2003.
6.3 2010 hip-replacement recall. 6.4 2010 Tylenol ... (J&J) is an American ... In September of the same year Johnson & Johnson Medical GmbH acquired Emerging Implant ...
The U.S. health regulator said it had received reports of pediatric and adult patients suffering burn injuries when the tools, sold under the brand names MEGA 2000 and MEGA SOFT Reusable Patient ...
The Committee on Oversight and Government Reform today held its hearing on Johnson & Johnson's (JNJ) recall of children's medicine -- the largest in the history of the U.S. Food and Drug ...
Following the 2010 DePuy Hip Recall, Lanier represented plaintiffs in several lawsuits against Johnson & Johnson and DePuy Synthes, which Johnson & Johnson acquired in 1998. [16] The implants were said to cause a build-up of metal ions in the blood, causing groin pain, allergic reactions, bone erosion and tissue death. [17]